132 related articles for article (PubMed ID: 14534542)
1. BRAF and KRAS mutations in stomach cancer.
Lee SH; Lee JW; Soung YH; Kim HS; Park WS; Kim SY; Lee JH; Park JY; Cho YG; Kim CJ; Nam SW; Kim SH; Lee JY; Yoo NJ
Oncogene; 2003 Oct; 22(44):6942-5. PubMed ID: 14534542
[TBL] [Abstract][Full Text] [Related]
2. BRAF mutations in non-Hodgkin's lymphoma.
Lee JW; Yoo NJ; Soung YH; Kim HS; Park WS; Kim SY; Lee JH; Park JY; Cho YG; Kim CJ; Ko YH; Kim SH; Nam SW; Lee JY; Lee SH
Br J Cancer; 2003 Nov; 89(10):1958-60. PubMed ID: 14612909
[TBL] [Abstract][Full Text] [Related]
3. BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency.
Oliveira C; Pinto M; Duval A; Brennetot C; Domingo E; Espín E; Armengol M; Yamamoto H; Hamelin R; Seruca R; Schwartz S
Oncogene; 2003 Dec; 22(57):9192-6. PubMed ID: 14668801
[TBL] [Abstract][Full Text] [Related]
4. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.
Soares P; Trovisco V; Rocha AS; Lima J; Castro P; Preto A; Máximo V; Botelho T; Seruca R; Sobrinho-Simões M
Oncogene; 2003 Jul; 22(29):4578-80. PubMed ID: 12881714
[TBL] [Abstract][Full Text] [Related]
5. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
[TBL] [Abstract][Full Text] [Related]
6. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
[TBL] [Abstract][Full Text] [Related]
7. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
8. BRAF mutations in papillary carcinomas of the thyroid.
Fukushima T; Suzuki S; Mashiko M; Ohtake T; Endo Y; Takebayashi Y; Sekikawa K; Hagiwara K; Takenoshita S
Oncogene; 2003 Sep; 22(41):6455-7. PubMed ID: 14508525
[TBL] [Abstract][Full Text] [Related]
9. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
Sieben NL; Macropoulos P; Roemen GM; Kolkman-Uljee SM; Jan Fleuren G; Houmadi R; Diss T; Warren B; Al Adnani M; De Goeij AP; Krausz T; Flanagan AM
J Pathol; 2004 Mar; 202(3):336-40. PubMed ID: 14991899
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the BRAF gene in squamous cell carcinoma of the head and neck.
Weber A; Langhanki L; Sommerer F; Markwarth A; Wittekind C; Tannapfel A
Oncogene; 2003 Jul; 22(30):4757-9. PubMed ID: 12879021
[TBL] [Abstract][Full Text] [Related]
11. RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers.
Mutch DG; Powell MA; Mallon MA; Goodfellow PJ
Am J Obstet Gynecol; 2004 Apr; 190(4):935-42. PubMed ID: 15118616
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers.
Kim IJ; Park JH; Kang HC; Shin Y; Park HW; Park HR; Ku JL; Lim SB; Park JG
Hum Genet; 2003 Dec; 114(1):118-20. PubMed ID: 14513361
[TBL] [Abstract][Full Text] [Related]
13. Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors.
Ho CL; Kurman RJ; Dehari R; Wang TL; Shih IeM
Cancer Res; 2004 Oct; 64(19):6915-8. PubMed ID: 15466181
[TBL] [Abstract][Full Text] [Related]
14. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.
Chan TL; Zhao W; Leung SY; Yuen ST;
Cancer Res; 2003 Aug; 63(16):4878-81. PubMed ID: 12941809
[TBL] [Abstract][Full Text] [Related]
15. BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas.
Wu M; Semba S; Oue N; Ikehara N; Yasui W; Yokozaki H
Gastric Cancer; 2004; 7(4):246-53. PubMed ID: 15616773
[TBL] [Abstract][Full Text] [Related]
16. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
[TBL] [Abstract][Full Text] [Related]
17. Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma.
Sommerer F; Vieth M; Markwarth A; Röhrich K; Vomschloss S; May A; Ell C; Stolte M; Hengge UR; Wittekind C; Tannapfel A
Oncogene; 2004 Jan; 23(2):554-8. PubMed ID: 14724583
[TBL] [Abstract][Full Text] [Related]
18. BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas.
Puxeddu E; Moretti S; Elisei R; Romei C; Pascucci R; Martinelli M; Marino C; Avenia N; Rossi ED; Fadda G; Cavaliere A; Ribacchi R; Falorni A; Pontecorvi A; Pacini F; Pinchera A; Santeusanio F
J Clin Endocrinol Metab; 2004 May; 89(5):2414-20. PubMed ID: 15126572
[TBL] [Abstract][Full Text] [Related]
19. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
[TBL] [Abstract][Full Text] [Related]
20. Mutations of BRAF and KRAS in gastric cancer and their association with microsatellite instability.
Zhao W; Chan TL; Chu KM; Chan AS; Stratton MR; Yuen ST; Leung SY
Int J Cancer; 2004 Jan; 108(1):167-9. PubMed ID: 14618633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
